YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Purpose-built research, incubator and laboratory space will leverage Purdue's R1 capabilities and Elanco's animal health leadership to advance One Health innovation in Indianapolis INDIANAPOLIS, IN / ACCESS Newswire / October 7, 2026 / The…
2 Cash-Producing Stocks for Long-Term Investors and 1 Facing Headwinds Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, l…
1 Mid-Cap Stock to Keep an Eye On and 2 We Ignore Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them…
INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026. Jeff Simmons, president and CEO, will participate in a fir…
3 Reasons to Sell ELAN and 1 Stock to Buy Instead Elanco currently trades at $23.15 per share and has shown little upside over the past six months, posting a small loss of 1.1%. The stock also fell short of the S&P 500's 14.2% gain during…
Innovation that protects against these pests is driving stronger Elanco base business and overall share gains. Elanco confirms U.S. Pet Health is on track to expectations of high-single digit to low double-digit growth in the second half o…
Elanco Animal Health (ELAN) drew fresh attention after its latest closing price of US$23.17. This put recent share moves and the company's improving annual revenue and net income figures in sharper focus for investors. Recent moves show mi…
INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the…
INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Jeff Simmons, president and CEO, Bob VanHimbergen, e…
Lawrence Erik Kurzius, Director at Elanco Animal Health(NYSE:ELAN), purchased 40,000 shares of common stock at $23.40 per share on Aug. 20, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value $…
Key Points Interested in Braveheart Bio, Inc.? Here are five stocks we like better. Insiders are heavily buying speculative pharma stocks in the third quarter, signaling confidence. Braveheart Bio and BlossomHill Therapeutics are early-sta…
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline INDIANAPOLIS, IN / ACCESS Newswire / August 31, 2026 / Elanco Animal Health Incorp…
3 Stocks Under $50 That Concern Us Stocks in the $10-50 range offer a sweet spot between affordability and stability as they're typically more established than penny stocks. But their headline prices don't guarantee quality, and investors…
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline INDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYS…
2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos…
Paul Herendeen, Director at Elanco Animal Health (NYSE:ELAN), purchased 10,000 shares of common stock on Aug. 7, 2026, according to an SEC Form 4 filing. Company snapshot Elanco Animal Health is a healthcare company based in Indianapolis.…
1 of Wall Street's Favorite Stocks on Our Watchlist and 2 We Find Risky Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it's important to remain skeptical because…
5 Must-Read Analyst Questions From Elanco's Q2 Earnings Call Elanco's results for the second quarter were positively received by the market, reflecting momentum across both its Pet Health and Farm Animal businesses. Management attributed g…
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Jeffrey Simmons Chief Financial Officer - Bob VanHimbergen Vice President of Investor Relations and ESG -…
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Jeffrey SimmonsChief Financial Officer - Bob VanHimbergenVice President of Investor Relations and ESG - T…
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital…
In early August 2026, Elanco Animal Health reported Q2 sales of US$1,368 million and net income of US$54 million, alongside an FDA Emergency Use Authorization for its CLiK Extra screwworm-prevention spray across multiple livestock and wild…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Elanco Animal Health (ELAN) is back in focus after receiving U.S. Food and Drug Administration Emer…
Key Points Interested in Elanco Animal Health Incorporated? Here are five stocks we like better. Strong Q2 performance: Elanco reported revenue of $1.368 billion, up 10% year over year, while adjusted EBITDA rose 21% to $288 million and ad…
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital…
[US Food and Drug Administration (FDA)] * The U.S. Food and Drug Administration has granted an emergency use authorization for Elanco Animal Health’s (ELAN [https://seekingalpha.com/symbol/ELAN]) antiparasitic therapy CLiK Extra as a treat…
Elanco Animal Health President and CEO Jeff Simmons discusses what's behind the company's increased profit and revenue forecasts. Speaking on "Bloomberg The Close," Simmons also comments on the recent surge in tick bites and consumer spend…
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Elanco Animal Health Incorporated (ELAN). But which of these two stocks offers value investors a better bang for the…
This article first appeared on GuruFocus. Revenue: $1.368 billion, up 10% reported; organic constant currency revenue grew 8%. Organic Growth Drivers: 6% increase in volume and 2% contribution from price. Pet Health Revenue (Organic CC): T…
Elanco Animal Health Incorporated (ELAN) reported $1.37 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 10.2%. EPS of $0.34 for the same period compares to $0.26 a year ago. The reported revenu…
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago. These figures are adjusted for…
Elanco's (NYSE:ELAN) Q2 CY2026: Strong Sales, Stock Soars Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 10.2% year on year to $1.37 billion. Guidance for next quar…
* Elanco press release [https://seekingalpha.com/pr/20607348-elanco-animal-health-reports-second-quarter-2026-results] (ELAN [https://seekingalpha.com/symbol/ELAN]): Q2 Non-GAAP EPS of $0.34 beats by $0.07. * Revenue of $1.37B (+10.5% Y/Y)…
Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second Quarter 2026 Financial Results: Revenue of $1,368 million, an increase of 10% year-over-year; 8% organic constant currency growth Reported…
Major earnings expected before the bell on Wednesday include: * The Walt Disney Company (DIS [https://seekingalpha.com/symbol/DIS]) * Eli Lilly and Company (LLY [https://seekingalpha.com/symbol/LLY]) * Shopify (SHOP [https://seekingalpha.c…
Report highlights Elanco's impact through innovation, expanded access to animal care, a stronger and more sustainable food system and investment in people and communities INDIANAPOLIS, IN / ACCESS Newswire / August 3, 2026 / Elanco Animal…